Literature DB >> 18768732

Osteoporosis primer for the vertebroplasty practitioner: expanding the focus beyond needles and cement.

A E Kearns1, D F Kallmes.   

Abstract

Osteoporosis is a common cause of vertebral compression fractures. Although vertebroplasty is used to treat the pain, the risk of additional compression fractures is very high in these patients. Adequate evaluation and management of the underlying osteoporosis is critical to reducing the risk of subsequent fractures. Such an evaluation involves understanding the underlying physiology of osteoporosis and the role of calcium, vitamin D, prescription medication, and lifestyle changes. This brief review is intended to familiarize neuroradiologists with these aspects so they can advise patients about optimizing fracture risk reduction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768732      PMCID: PMC8118932          DOI: 10.3174/ajnr.A1176

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  47 in total

Review 1.  Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy.

Authors:  B L Riggs; L J Melton; W M O'Fallon
Journal:  Bone       Date:  1996-03       Impact factor: 4.398

2.  Risk of new vertebral fracture in the year following a fracture.

Authors:  R Lindsay; S L Silverman; C Cooper; D A Hanley; I Barton; S B Broy; A Licata; L Benhamou; P Geusens; K Flowers; H Stracke; E Seeman
Journal:  JAMA       Date:  2001-01-17       Impact factor: 56.272

3.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Authors:  D M Black; S R Cummings; D B Karpf; J A Cauley; D E Thompson; M C Nevitt; D C Bauer; H K Genant; W L Haskell; R Marcus; S M Ott; J C Torner; S A Quandt; T F Reiss; K E Ensrud
Journal:  Lancet       Date:  1996-12-07       Impact factor: 79.321

4.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

Review 5.  Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women.

Authors:  Emmanuel Papadimitropoulos; George Wells; Beverley Shea; William Gillespie; Bruce Weaver; Nicole Zytaruk; Ann Cranney; Jonathan Adachi; Peter Tugwell; Robert Josse; Carol Greenwood; Gordon Guyatt
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

Review 6.  Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis.

Authors:  Beverley Shea; George Wells; Ann Cranney; Nicole Zytaruk; Vivian Robinson; Lauren Griffith; Zulma Ortiz; Joan Peterson; Jonathan Adachi; Peter Tugwell; Gordon Guyatt
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

7.  Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women.

Authors:  Kaisa K Ivaska; Paul Gerdhem; Kristina Akesson; Patrick Garnero; Karl J Obrant
Journal:  J Bone Miner Res       Date:  2007-08       Impact factor: 6.741

8.  Calcium plus vitamin D supplementation and the risk of fractures.

Authors:  Rebecca D Jackson; Andrea Z LaCroix; Margery Gass; Robert B Wallace; John Robbins; Cora E Lewis; Tamsen Bassford; Shirley A A Beresford; Henry R Black; Patricia Blanchette; Denise E Bonds; Robert L Brunner; Robert G Brzyski; Bette Caan; Jane A Cauley; Rowan T Chlebowski; Steven R Cummings; Iris Granek; Jennifer Hays; Gerardo Heiss; Susan L Hendrix; Barbara V Howard; Judith Hsia; F Allan Hubbell; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis H Kuller; Robert D Langer; Norman L Lasser; Marian C Limacher; Shari Ludlam; JoAnn E Manson; Karen L Margolis; Joan McGowan; Judith K Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Gloria E Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Evelyn Whitlock; Garnet L Anderson; Annlouise R Assaf; David Barad
Journal:  N Engl J Med       Date:  2006-02-16       Impact factor: 91.245

9.  Bone remodeling rate and remodeling balance are not co-regulated in adulthood: implications for the use of activation frequency as an index of remodeling rate.

Authors:  Juliet E Compston; Shobna Vedi; Stephen Kaptoge; Ego Seeman
Journal:  J Bone Miner Res       Date:  2007-07       Impact factor: 6.741

10.  Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D.

Authors:  Michael F Holick; Rachael M Biancuzzo; Tai C Chen; Ellen K Klein; Azzie Young; Douglass Bibuld; Richard Reitz; Wael Salameh; Allen Ameri; Andrew D Tannenbaum
Journal:  J Clin Endocrinol Metab       Date:  2007-12-18       Impact factor: 5.958

View more
  2 in total

1.  Asymptomatic and unrecognized cement pulmonary embolism commonly occurs with vertebroplasty.

Authors:  M T Luetmer; B J Bartholmai; A E Rad; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-17       Impact factor: 3.825

2.  Evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis.

Authors:  Chih-Chang Yeh; Yu-Han Su; Yu-Jhe Lin; Pin-Jyun Chen; Chung-Sheng Shi; Cheng-Nan Chen; Hsin-I Chang
Journal:  Drug Des Devel Ther       Date:  2015-04-20       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.